Agrow is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU guide on biocide technical equivalence

The European Chemicals Agency (ECHA) has issued guidelines for companies seeking to apply for recognition that their biocide active ingredient is technically equivalent to a "reference" or already approved ai. EU biocide registration rules, which cover non-crop pesticides, require an assessment of technical equivalence for approval of generic biocides (Agrow No 669, p 12) and for applications for a change in manufacturing location or process (Agrow No 664, p 9). The document covers how and when to apply for an assessment of technical equivalence, and provides information on the assessment process. The new EU biocidal products Regulation (528/2012) means that the assessment will now be performed by the ECHA. Under the previous EU biocidal products Directive (98/8), it was carried out by the relevant EU member-state regulatory authority.  The guidance is available at: http://echa.europa.eu/guidance-documents/guidance-on-biocides-legislation?panel=guidance_applications_technical_equivalence.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG000293

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel